by Market Overview:
An ambulatory infusion center provides infusion therapy services, which refer to a range of healthcare procedures where drugs or fluids are delivered into a patient’s body through an intravenous (IV) line on an outpatient basis. These centers help treat various medical conditions like cancer, autoimmune deficiency, rheumatoid arthritis, etc. through medications administered intravenously instead of orally. They offer convenience and reduce hospitalization costs for patients receiving long-term infusion therapy.
Market key trends:
One of the key trends in the ambulatory infusion center market is the growing preference for outpatient care. There is an increasing shift from inpatient to outpatient settings for administering IV therapies due to various advantages like convenience, reduced costs, and less risk of hospital-acquired infections. This trend is being driven by factors such as advancements in drug delivery, favorable reimbursement policies, and growing popularity of specialty pharmacies. Furthermore, increasing incidence of chronic diseases necessitating long-term IV therapies like cancer, autoimmune diseases and congestive heart failure is also propelling the demand for ambulatory infusion centers globally.
One of the key trends in the ambulatory infusion center market is the growing popularity of home infusion therapy. With advancements in treatment methods and availability of efficient home infusion pumps, many patients now prefer to receive infusion treatment at home instead of visiting hospital facilities regularly. This has significantly boosted the demand for ambulatory infusion services globally. Home infusion therapy allows patients to receive treatment in a comfortable environment while resuming their normal routine. It also helps avoid hospital stay and related costs. This trend is expected to further gain traction during the forecast period.
The global Ambulatory Infusion Center Market Size is estimated to be valued at US$ 60883.85 Mn in 2023 and is expected to exhibit a CAGR of 6.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
SWOT Analysis:
Strength: Ambulatory infusion centers offer convenience of treatment outside a hospital setting in a relaxed environment. This improves patient satisfaction and experience.
Weakness: High establishment and maintenance costs associated with setting up advanced infusion center facilities. Also, reliance on skilled nursing staff poses recruitment and retention challenges.
Opportunity: Growing geriatric population susceptible to chronic diseases provides large target population base. Increasing preference for home-based care also opens new avenues.
Threats: Stringent regulations and accreditation standards add complexity and compliance burden. Shortage of specialty drugs and skilled workforce can also impact service quality and operations.
Key Takeaways:
The global ambulatory infusion center market size was valued at US$ 60883.85 Mn in 2023 and is expected to reach over US$ 100000 Mn by 2030, expanding at a CAGR of 6.7% during the forecast period.
The market is driven by the increasing incidence of chronic diseases such as cancer, autoimmune disorders and infectious diseases. Long-term treatment methods such as chemotherapy, antibiotic therapy and hydration require frequent visits to infusion centers or hospitals which is both time-consuming and inconvenient for patients. This is boosting the demand for ambulatory infusion services.
On the regional front, North America dominated the global market in 2023 and is expected to maintain its lead through 2030. This can be attributed to growing geriatric population, rising healthcare spending, favorable reimbursement policies, and increasing adoption of home-based healthcare services in the region. Asia Pacific is anticipated to witness fastest growth during the forecast period supported by improving access to healthcare facilities, expansion of private healthcare insurance, and growing medical tourism in the region.
Some of the key players operating in the ambulatory infusion center market include Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc., IVX Health and Precision Healthcare. These players focus on expanding service portfolios and telehealth offerings to cater to rising demand for convenient home infusion services. Strategic collaborations with hospitals and insurers also remain crucial for market participation.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
